Perseus Proteomics

About:

Perseus Proteomics is a biotech company that offers antibody drug development, antibody research support services, and sales.

Website: https://www.ppmx.com/

Top Investors: SMBC Venture Capital, Mitsubishi UFJ Capital, SBI Investment, Mizuho Capital, DBJ Capital

Description:

PePerseus Proteomics is a drug discovery biotechnology venture that uses advanced antibody technology to pursue superior antibody production technology and create new medicines powerfully for people around the world who are waiting for better medical care .

Total Funding Amount:

5.44B JPY

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2001-02-01

Contact Email:

info(AT)ppmx.com

Founders:

Takuya Yokokawa

Number of Employees:

11-50

Last Funding Date:

2020-11-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai